Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
1995-5-4
|
| pubmed:abstractText |
Recent studies of the molecular biology of cancer have demonstrated that p53 tumor suppressor gene aberration is associated with the development and progression of several different cancer types.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0008-543X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
75
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2037-44
|
| pubmed:dateRevised |
2010-3-24
|
| pubmed:meshHeading | |
| pubmed:year |
1995
|
| pubmed:articleTitle |
p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome.
|
| pubmed:affiliation |
Institute of Otolaryngology-Head & Neck Surgery, University of Florence, Italy.
|
| pubmed:publicationType |
Journal Article
|